Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.560
+0.090 (6.12%)
At close: Aug 29, 2024, 4:00 PM
1.590
+0.030 (1.92%)
Pre-market: Aug 30, 2024, 5:59 AM EDT
Silexion Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| 2013 | 2012 |
Dec '13 Dec 31, 2013 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Cash & Equivalents | 0.79 | 0.79 | 1.6 |
Cash & Short-Term Investments | 0.79 | 0.79 | 1.6 |
Cash Growth | - | -50.69% | - |
Other Receivables | 0.09 | 0.09 | 0.16 |
Receivables | 0.09 | 0.09 | 0.16 |
Prepaid Expenses | 0.01 | 0.01 | - |
Other Current Assets | 0.04 | 0.04 | 0.03 |
Total Current Assets | 0.93 | 0.93 | 1.79 |
Property, Plant & Equipment | 0.01 | 0.01 | 0.01 |
Accounts Payable | 0.1 | 0.1 | 0.08 |
Accrued Expenses | 0.14 | 0.14 | 0.09 |
Total Current Liabilities | 0.24 | 0.24 | 0.17 |
Additional Paid-In Capital | 5.16 | 5.16 | 4.74 |
Retained Earnings | -4.47 | -4.47 | -3.11 |
Total Liabilities & Equity | 0.94 | 0.94 | 1.8 |
Net Cash (Debt) | 0.79 | 0.79 | 1.6 |
Net Cash Growth | - | -50.69% | - |
Net Cash Per Share | 5.29 | 5.29 | 12.44 |
Filing Date Shares Outstanding | 0.15 | 0.15 | 0.15 |
Total Common Shares Outstanding | 0.15 | 0.15 | 0.15 |
Working Capital | 0.69 | 0.69 | 1.62 |
Book Value Per Share | 4.67 | 4.67 | 10.91 |
Tangible Book Value | 0.7 | 0.7 | 1.63 |
Tangible Book Value Per Share | 4.67 | 4.67 | 10.91 |
Machinery | 0.02 | 0.02 | 0.01 |
Source: S&P Capital IQ. Standard template.
Financial Sources.